Salix Pharmaceuticals Ltd (NASDAQ:SLXP)
| 59.28 Data as of May 17 |  +0.09 / +0.15%Today’s Change | 37.52 Today|||52-Week Range 60.20 | +46.47% Year-to-Date |
Latest SLXP News | Press Releases
| Good News for Roche's Tarceva - Analyst Blog May 16 / Zacks.com | Salix Stock Hits New 52-Week High (SLXP) May 15 / TheStreet.com |
| Good News for Novartis' Ilaris - Analyst Blog May 15 / Zacks.com | Salix Beats on Earnings - Analyst Blog May 14 / Zacks.com |
| FDA Accepts Merck BLA - Analyst Blog May 15 / Zacks.com | The Gory Details on Salix Pharmaceuticals's Double Miss May 10 / MotleyFool.com |
Today’s Trading
| Previous close | 59.19 |
| Today’s open | 59.40 |
| Day’s range | 58.75 - 59.56 |
| Volume | 420,834 |
| Average volume (3 months) | 528,022 |
| Market cap | $3.6B |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | -29.86% |
| Earnings growth (this year) | +6.87% |
| Earnings growth (next 5 years) | +22.00% |
| Revenue growth (last year) | +36.07% |
| P/E ratio | 49.0 |
| Price/Sales | 3.23 |
| Price/Book | 6.44 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MDVNMedivation Inc | -0.76 | -1.57% |
| UTHRUnited Therapeutics ... | +0.69 | +1.01% |
| JAZZJazz Pharmaceuticals... | +0.04 | +0.07% |
| ENDPEndo Health Solution... | +1.07 | +3.21% |
Data as of 4:00pm ET, 05/17/2013
Financials
| Next reporting date | August 12, 2013 |
| EPS forecast (this quarter) | $0.81 |
| Annual revenue (last year) | $735.4M |
| Annual profit (last year) | $64.2M |
| Net profit margin | 8.74% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Carolyn J. Logan |
Chief Financial Officer & EVP-Administration Adam C. Derbyshire, MBA |
Corporate headquarters Raleigh, North Carolina |
Forecasts
